Screen Detected Ductal Carcinoma in Situ (DCIS) of the Breast

NHS Cancer Screening Programme Logo
Feedback and Enquires to the NHS Cancer Screening Programmes
NHS Cancer Screening
NHS Cancer Screening Press Room
NHS Breast Screening Programme
NHS Cervical Screening Programme
NHS Bowel Cancer Screening Programme
NHS Prostate Cancer Risk Management

Breast Screening Annual Review (UK)
Breast screening statistics
Breast Screening Equipment Guidance

Research Literature Online Database

ISBN 1 871997 60 7

Now that the government initiated National Breast Screening Programme is under way, asymptomatic women with screen detected ductal carcinoma in situ (DCIS) are being referred for treatment. In these background notes an attempt has been made to outline the pros and cons of different treatments and the reason behind the design of this trial.

Prepared by the Working Party of the BCTCS (Breast Cancer Trials Coordinating Sub Committee) and the UKCCR (UK Coordinating Committee on Cancer Research). Published December 1989.

Copies of the protocol are no longer available but the full research report, Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia and New Zealand: randomised controlled trial was published in The Lancet in July 2003. See Lancet 2003; 362: 95-102.

NHS Breast Cancer Screening Publications

Search this site for:
Breast Screening Publications Index

Breast screening programme index

What happens at a
breast screening unit?

What are the risks of breast screening?

Frequently Asked Questions (FAQs)

Breast awareness

Benign breast disease

DCIS (Ductal Carcinoma
in Situ)

Diethylstilbestrol (DES) exposed women

Breast cancer

Quality assurance

Training

Programme statistics

Archived statistics bulletins

Research

Publications index

Programme posters

Archive

Useful links

Home | Breast Screening | Cervical Screening | Bowel Cancer Screening | Prostate Cancer Risk Management | Screening News | Contact NHS Screening ]

The national office can be contacted at:

NHS Cancer Screening Programmes
Fulwood House
Old Fulwood Road
SHEFFIELD S10 3TH

Tel: 0114 271 1060
Fax: 0114 271 1089
E-mail: [email protected]

Press and media enquiries should be made to:

NHS Cancer Screening Press Office
100 Gray's Inn Road
London
WC1X 8AL

Tel: 020 7400 4499
Fax: 020 7400 4481
E-mail: [email protected]

breastscreen/publications/pe-03.html
site created by The Net Effect
©NHS Cancer Screening Programmes